Presbia PLC (NASDAQ:LENS) Files An 8-K Other Events
Item8.01 Other Events
On February22, 2017, the Company issued a press release
announcing the extension of the subscription period for the
currently ongoing rights offering, a copy of which is attached as
Exhibit 99.1 hereto. The subscription period will be extended
from February23, 2017 to 5:00 p.m. Eastern Time on March8, 2017.
Item9.01Financial Statements and Exhibits
| (d) | Exhibits. |
99.1Presbia PLC press release dated February22, 2017.
About Presbia PLC (NASDAQ:LENS)
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders. Presbia PLC (NASDAQ:LENS) Recent Trading Information
Presbia PLC (NASDAQ:LENS) closed its last trading session up +0.08 at 3.28 with 916 shares trading hands.
